To bring new treatments to patients.

We have advanced multiple drug candidates into human clinical trials and we have a broad and diverse pipeline of drug targets behind our clinical programs with several additional compounds in preclinical research and development.

We have developed a portfolio of drug candidates to enhance our opportunities for success.  We are supported by experts, partners and investors in our efforts to transform our vision into a commercial reality.  An experienced in-house research and development team, and alliances with large pharmaceutical and biotechnology companies will enable our success.